Sponsors: []Modifications: ; and(EEE)  3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also knownas U-47700.If approved by two-thirds of all the members elected to each house, this bill takes effectupon approval by the governor, or the day following the constitutional time limit of UtahConstitution, Article VII, Section 8, without the governor's signature, or in the case of a veto,the date of veto override.Full text:



1     CONTROLLED SUBSTANCE AMENDMENTS2     2017 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Paul Ray5     Senate Sponsor:  ____________6      7     LONG TITLE8     General Description:9          This bill modifies the Utah Controlled Substances Act regarding Schedule I.10     Highlighted Provisions:11          This bill:12                adds the substance13     3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide that is also14     known as U-47700 or "pink" to the list of controlled substances under Schedule I.15     Money Appropriated in this Bill:16          None17     Other Special Clauses:18          This bill provides a special effective date.19     Utah Code Sections Affected:20     AMENDS:21          58-37-4, as last amended by Laws of Utah 2015, Chapter 25822      23     Be it enacted by the Legislature of the state of Utah:24          Section 1.  Section 58-37-4 is amended to read:25          58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings26     required -- Specific substances included in schedules.27          (1)  There are established five schedules of controlled substances known as Schedules I,28     II, III, IV, and V which consist of substances listed in this section.29          (2)  Schedules I, II, III, IV, and V consist of the following drugs or other substances by30     the official name, common or usual name, chemical name, or brand name designated:31          (a)  Schedule I:32          (i)  Unless specifically excepted or unless listed in another schedule, any of the33     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and34     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific35     chemical designation:36          (A)  Acetyl-alpha-methylfentanyl37     (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);38          (B)  Acetylmethadol;39          (C)  Allylprodine;40          (D)  Alphacetylmethadol, except levo-alphacetylmethadol also known as41     levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;42          (E)  Alphameprodine;43          (F)  Alphamethadol;44          (G)  Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]45     propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);46          (H)  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-47     piperidinyl]-N-phenylpropanamide);48          (I)  Benzylpiperazine;49          (J)  Benzethidine;50          (K)  Betacetylmethadol;51          (L)  Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-52     piperidinyl]-N-phenylpropanamide);53          (M)  Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-54     phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;55          (N)  Betameprodine;56          (O)  Betamethadol;57          (P)  Betaprodine;58          (Q)  Clonitazene;59          (R)  Dextromoramide;60          (S)  Diampromide;61          (T)  Diethylthiambutene;62          (U)  Difenoxin;63          (V)  Dimenoxadol;64          (W)  Dimepheptanol;65          (X)  Dimethylthiambutene;66          (Y)  Dioxaphetyl butyrate;67          (Z)  Dipipanone;68          (AA)  Ethylmethylthiambutene;69          (BB)  Etonitazene;70          (CC)  Etoxeridine;71          (DD)  Furethidine;72          (EE)  Hydroxypethidine;73          (FF)  Ketobemidone;74          (GG)  Levomoramide;75          (HH)  Levophenacylmorphan;76          (II)  Morpheridine;77          (JJ)  MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);78          (KK)  Noracymethadol;79          (LL)  Norlevorphanol;80          (MM)  Normethadone;81          (NN)  Norpipanone;82          (OO)  Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]83     propanamide;84          (PP)  PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);85          (QQ)  Phenadoxone;86          (RR)  Phenampromide;87          (SS)  Phenomorphan;88          (TT)  Phenoperidine;89          (UU)  Piritramide;90          (VV)  Proheptazine;91          (WW)  Properidine;92          (XX)  Propiram;93          (YY)  Racemoramide;94          (ZZ)  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;95          (AAA)  Tilidine;96          (BBB)  Trimeperidine;97          (CCC)  3-methylfentanyl, including the optical and geometric isomers98     (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); [and]99          (DDD)  3-methylthiofentanyl100     (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)[.]; and101          (EEE)  3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also known102     as U-47700.103          (ii)  Unless specifically excepted or unless listed in another schedule, any of the104     following opium derivatives, their salts, isomers, and salts of isomers when the existence of the105     salts, isomers, and salts of isomers is possible within the specific chemical designation:106          (A)  Acetorphine;107          (B)  Acetyldihydrocodeine;108          (C)  Benzylmorphine;109          (D)  Codeine methylbromide;110          (E)  Codeine-N-Oxide;111          (F)  Cyprenorphine;112          (G)  Desomorphine;113          (H)  Dihydromorphine;114          (I)  Drotebanol;115          (J)  Etorphine (except hydrochloride salt);116          (K)  Heroin;117          (L)  Hydromorphinol;118          (M)  Methyldesorphine;119          (N)  Methylhydromorphine;120          (O)  Morphine methylbromide;121          (P)  Morphine methylsulfonate;122          (Q)  Morphine-N-Oxide;123          (R)  Myrophine;124          (S)  Nicocodeine;125          (T)  Nicomorphine;126          (U)  Normorphine;127          (V)  Pholcodine; and128          (W)  Thebacon.129          (iii)  Unless specifically excepted or unless listed in another schedule, any material,130     compound, mixture, or preparation which contains any quantity of the following hallucinogenic131     substances, or which contains any of their salts, isomers, and salts of isomers when the132     existence of the salts, isomers, and salts of isomers is possible within the specific chemical133     designation; as used in this Subsection (2)(a)(iii) only, "isomer" includes the optical, position,134     and geometric isomers:135          (A)  Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;136      -ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole;  -ET; and AET;137          (B)  4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:138     4-bromo-2,5-dimethoxy- -methylphenethylamine; 4-bromo-2,5-DMA;139          (C)  4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:140     2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;141          (D)  2,5-dimethoxyamphetamine, some trade or other names:142     2,5-dimethoxy- -methylphenethylamine; 2,5-DMA;143          (E)  2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;144          (F)  4-methoxyamphetamine, some trade or other names:145     4-methoxy- -methylphenethylamine; paramethoxyamphetamine, PMA;146          (G)  5-methoxy-3,4-methylenedioxyamphetamine;147          (H)  4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:148     4-methyl-2,5-dimethoxy- -methylphenethylamine; "DOM"; and "STP";149          (I)  3,4-methylenedioxy amphetamine;150          (J)  3,4-methylenedioxymethamphetamine (MDMA);151          (K)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-152     alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;153          (L)  N-hydroxy-3,4-methylenedioxyamphetamine, also known as154     N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;155          (M)  3,4,5-trimethoxy amphetamine;156          (N)  Bufotenine, some trade and other names:157     3-( -Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,158     N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;159          (O)  Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;160          (P)  Dimethyltryptamine, some trade or other names: DMT;161          (Q)  Ibogaine, some trade and other names:162     7-Ethyl-6,6 ,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino163     [5,4-b] indole; Tabernanthe iboga;164          (R)  Lysergic acid diethylamide;165          (S)  Marijuana;166          (T)  Mescaline;167          (U)  Parahexyl, some trade or other names:168     3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;169          (V)  Peyote, meaning all parts of the plant presently classified botanically as170     Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from171     any part of such plant, and every compound, manufacture, salts, derivative, mixture, or172     preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));173          (W)  N-ethyl-3-piperidyl benzilate;174          (X)  N-methyl-3-piperidyl benzilate;175          (Y)  Psilocybin;176          (Z)  Psilocyn;177          (AA)  Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis178     (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis179     plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,180     and their isomers with similar chemical structure and pharmacological activity to those181     substances contained in the plant, such as the following:  1 cis or trans tetrahydrocannabinol,182     and their optical isomers  6 cis or trans tetrahydrocannabinol, and their optical isomers  3,4183     cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these184     substances is not internationally standardized, compounds of these structures, regardless of185     numerical designation of atomic positions covered;186          (BB)  Ethylamine analog of phencyclidine, some trade or other names:187     N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,188     N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;189          (CC)  Pyrrolidine analog of phencyclidine, some trade or other names:190     1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;191          (DD)  Thiophene analog of phencyclidine, some trade or other names:192     1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and193          (EE)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.194          (iv)  Unless specifically excepted or unless listed in another schedule, any material195     compound, mixture, or preparation which contains any quantity of the following substances196     having a depressant effect on the central nervous system, including its salts, isomers, and salts197     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the198     specific chemical designation:199          (A)  Mecloqualone; and200          (B)  Methaqualone.201          (v)  Any material, compound, mixture, or preparation containing any quantity of the202     following substances having a stimulant effect on the central nervous system, including their203     salts, isomers, and salts of isomers:204          (A)  Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or205     4,5-dihydro-5-phenyl-2-oxazolamine;206          (B)  Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,207     alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;208          (C)  Fenethylline;209          (D)  Methcathinone, some other names: 2-(methylamino)-propiophenone;210     alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;211     alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;212     methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of213     optical isomers;214          (E)  ( )cis-4-methylaminorex (( )cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);215          (F)  N-ethylamphetamine; and216          (G)  N,N-dimethylamphetamine, also known as217     N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.218          (vi)  Any material, compound, mixture, or preparation which contains any quantity of219     the following substances, including their optical isomers, salts, and salts of isomers, subject to220     temporary emergency scheduling:221          (A)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and222          (B)  N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).223          (vii)  Unless specifically excepted or unless listed in another schedule, any material,224     compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate225     (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.226          (b)  Schedule II:227          (i)  Unless specifically excepted or unless listed in another schedule, any of the228     following substances whether produced directly or indirectly by extraction from substances of229     vegetable origin, or independently by means of chemical synthesis, or by a combination of230     extraction and chemical synthesis:231          (A)  Opium and opiate, and any salt, compound, derivative, or preparation of opium or232     opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,233     and their respective salts, but including:234          (I)  Raw opium;235          (II)  Opium extracts;236          (III)  Opium fluid;237          (IV)  Powdered opium;238          (V)  Granulated opium;239          (VI)  Tincture of opium;240          (VII)  Codeine;241          (VIII)  Ethylmorphine;242          (IX)  Etorphine hydrochloride;243          (X)  Hydrocodone;244          (XI)  Hydromorphone;245          (XII)  Metopon;246          (XIII)  Morphine;247          (XIV)  Oxycodone;248          (XV)  Oxymorphone; and249          (XVI)  Thebaine;250          (B)  Any salt, compound, derivative, or preparation which is chemically equivalent or251     identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these252     substances may not include the isoquinoline alkaloids of opium;253          (C)  Opium poppy and poppy straw;254          (D)  Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and255     any salt, compound, derivative, or preparation which is chemically equivalent or identical with256     any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,257     and salts of isomers and derivatives, whether derived from the coca plant or synthetically258     produced, except the substances may not include decocainized coca leaves or extraction of coca259     leaves, which extractions do not contain cocaine or ecgonine; and260          (E)  Concentrate of poppy straw, which means the crude extract of poppy straw in either261     liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.262          (ii)  Unless specifically excepted or unless listed in another schedule, any of the263     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and264     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific265     chemical designation, except dextrorphan and levopropoxyphene:266          (A)  Alfentanil;267          (B)  Alphaprodine;268          (C)  Anileridine;269          (D)  Bezitramide;270          (E)  Bulk dextropropoxyphene (nondosage forms);271          (F)  Carfentanil;272          (G)  Dihydrocodeine;273          (H)  Diphenoxylate;274          (I)  Fentanyl;275          (J)  Isomethadone;276          (K)  Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,277     levomethadyl acetate, or LAAM;278          (L)  Levomethorphan;279          (M)  Levorphanol;280          (N)  Metazocine;281          (O)  Methadone;282          (P)  Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;283          (Q)  Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic284     acid;285          (R)  Pethidine (meperidine);286          (S)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;287          (T)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;288          (U)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;289          (V)  Phenazocine;290          (W)  Piminodine;291          (X)  Racemethorphan;292          (Y)  Racemorphan;293          (Z)  Remifentanil; and294          (AA)  Sufentanil.295          (iii)  Unless specifically excepted or unless listed in another schedule, any material,296     compound, mixture, or preparation which contains any quantity of the following substances297     having a stimulant effect on the central nervous system:298          (A)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;299          (B)  Methamphetamine, its salts, isomers, and salts of its isomers;300          (C)  Phenmetrazine and its salts; and301          (D)  Methylphenidate.302          (iv)  Unless specifically excepted or unless listed in another schedule, any material,303     compound, mixture, or preparation which contains any quantity of the following substances304     having a depressant effect on the central nervous system, including its salts, isomers, and salts305     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the306     specific chemical designation:307          (A)  Amobarbital;308          (B)  Glutethimide;309          (C)  Pentobarbital;310          (D)  Phencyclidine;311          (E)  Phencyclidine immediate precursors: 1-phenylcyclohexylamine and312     1-piperidinocyclohexanecarbonitrile (PCC); and313          (F)  Secobarbital.314          (v) (A)  Unless specifically excepted or unless listed in another schedule, any material,315     compound, mixture, or preparation which contains any quantity of Phenylacetone.316          (B)  Some of these substances may be known by trade or other names:317     phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.318          (vi)  Nabilone, another name for nabilone:319     ( )-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,320     6-dimethyl-9H-dibenzo[b,d]pyran-9-one.321          (c)  Schedule III:322          (i)  Unless specifically excepted or unless listed in another schedule, any material,323     compound, mixture, or preparation which contains any quantity of the following substances324     having a stimulant effect on the central nervous system, including its salts, isomers whether325     optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,326     and salts of isomers is possible within the specific chemical designation:327          (A)  Those compounds, mixtures, or preparations in dosage unit form containing any328     stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were329     listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the330     Code of Federal Regulations, and any other drug of the quantitive composition shown in that331     list for those drugs or which is the same except that it contains a lesser quantity of controlled332     substances;333          (B)  Benzphetamine;334          (C)  Chlorphentermine;335          (D)  Clortermine; and336          (E)  Phendimetrazine.337          (ii)  Unless specifically excepted or unless listed in another schedule, any material,338     compound, mixture, or preparation which contains any quantity of the following substances339     having a depressant effect on the central nervous system:340          (A)  Any compound, mixture, or preparation containing amobarbital, secobarbital,341     pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients342     which are not listed in any schedule;343          (B)  Any suppository dosage form containing amobarbital, secobarbital, or344     pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug345     Administration for marketing only as a suppository;346          (C)  Any substance which contains any quantity of a derivative of barbituric acid or any347     salt of any of them;348          (D)  Chlorhexadol;349          (E)  Buprenorphine;350          (F)  Any drug product containing gamma hydroxybutyric acid, including its salts,351     isomers, and salts of isomers, for which an application is approved under the federal Food,352     Drug, and Cosmetic Act, Section 505;353          (G)  Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:354       -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;355          (H)  Lysergic acid;356          (I)  Lysergic acid amide;357          (J)  Methyprylon;358          (K)  Sulfondiethylmethane;359          (L)  Sulfonethylmethane;360          (M)  Sulfonmethane; and361          (N)  Tiletamine and zolazepam or any of their salts, some trade or other names for a362     tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:363     2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:364     4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,365     flupyrazapon.366          (iii)  Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a367     U.S. Food and Drug Administration approved drug product, some other names for dronabinol:368     (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or369     (-)-delta-9-(trans)-tetrahydrocannabinol.370          (iv)  Nalorphine.371          (v)  Unless specifically excepted or unless listed in another schedule, any material,372     compound, mixture, or preparation containing limited quantities of any of the following373     narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:374          (A)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90375     milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of376     opium;377          (B)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90378     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized379     therapeutic amounts;380          (C)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more381     than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline382     alkaloid of opium;383          (D)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more384     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in385     recognized therapeutic amounts;386          (E)  Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90387     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized388     therapeutic amounts;389          (F)  Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more390     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in391     recognized therapeutic amounts;392          (G)  Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not393     more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in394     recognized therapeutic amounts; and395          (H)  Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with396     one or more active, non-narcotic ingredients in recognized therapeutic amounts.397          (vi)  Unless specifically excepted or unless listed in another schedule, anabolic steroids398     including any of the following or any isomer, ester, salt, or derivative of the following that399     promotes muscle growth:400          (A)  Boldenone;401          (B)  Chlorotestosterone (4-chlortestosterone);402          (C)  Clostebol;403          (D)  Dehydrochlormethyltestosterone;404          (E)  Dihydrotestosterone (4-dihydrotestosterone);405          (F)  Drostanolone;406          (G)  Ethylestrenol;407          (H)  Fluoxymesterone;408          (I)  Formebulone (formebolone);409          (J)  Mesterolone;410          (K)  Methandienone;411          (L)  Methandranone;412          (M)  Methandriol;413          (N)  Methandrostenolone;414          (O)  Methenolone;415          (P)  Methyltestosterone;416          (Q)  Mibolerone;417          (R)  Nandrolone;418          (S)  Norethandrolone;419          (T)  Oxandrolone;420          (U)  Oxymesterone;421          (V)  Oxymetholone;422          (W)  Stanolone;423          (X)  Stanozolol;424          (Y)  Testolactone;425          (Z)  Testosterone; and426          (AA)  Trenbolone.427          (vii)  Anabolic steroids expressly intended for administration through implants to cattle428     or other nonhuman species, and approved by the Secretary of Health and Human Services for429     use, may not be classified as a controlled substance.430          (d)  Schedule IV:431          (i)  Unless specifically excepted or unless listed in another schedule, any material,432     compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not433     less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.434          (ii)  Unless specifically excepted or unless listed in another schedule, any material,435     compound, mixture, or preparation which contains any quantity of the following substances,436     including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and437     salts of isomers is possible within the specific chemical designation:438          (A)  Alprazolam;439          (B)  Barbital;440          (C)  Bromazepam;441          (D)  Butorphanol;442          (E)  Camazepam;443          (F)  Carisoprodol;444          (G)  Chloral betaine;445          (H)  Chloral hydrate;446          (I)  Chlordiazepoxide;447          (J)  Clobazam;448          (K)  Clonazepam;449          (L)  Clorazepate;450          (M)  Clotiazepam;451          (N)  Cloxazolam;452          (O)  Delorazepam;453          (P)  Diazepam;454          (Q)  Dichloralphenazone;455          (R)  Estazolam;456          (S)  Ethchlorvynol;457          (T)  Ethinamate;458          (U)  Ethyl loflazepate;459          (V)  Fludiazepam;460          (W)  Flunitrazepam;461          (X)  Flurazepam;462          (Y)  Halazepam;463          (Z)  Haloxazolam;464          (AA)  Ketazolam;465          (BB)  Loprazolam;466          (CC)  Lorazepam;467          (DD)  Lormetazepam;468          (EE)  Mebutamate;469          (FF)  Medazepam;470          (GG)  Meprobamate;471          (HH)  Methohexital;472          (II)  Methylphenobarbital (mephobarbital);473          (JJ)  Midazolam;474          (KK)  Nimetazepam;475          (LL)  Nitrazepam;476          (MM)  Nordiazepam;477          (NN)  Oxazepam;478          (OO)  Oxazolam;479          (PP)  Paraldehyde;480          (QQ)  Pentazocine;481          (RR)  Petrichloral;482          (SS)  Phenobarbital;483          (TT)  Pinazepam;484          (UU)  Prazepam;485          (VV)  Quazepam;486          (WW)  Temazepam;487          (XX)  Tetrazepam;488          (YY)  Triazolam;489          (ZZ)  Zaleplon; and490          (AAA)  Zolpidem.491          (iii)  Any material, compound, mixture, or preparation of fenfluramine which contains492     any quantity of the following substances, including its salts, isomers whether optical, position,493     or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of494     isomers is possible.495          (iv)  Unless specifically excepted or unless listed in another schedule, any material,496     compound, mixture, or preparation which contains any quantity of the following substances497     having a stimulant effect on the central nervous system, including its salts, isomers whether498     optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,499     isomers, and salts of isomers is possible within the specific chemical designation:500          (A)  Cathine ((+)-norpseudoephedrine);501          (B)  Diethylpropion;502          (C)  Fencamfamine;503          (D)  Fenproprex;504          (E)  Mazindol;505          (F)  Mefenorex;506          (G)  Modafinil;507          (H)  Pemoline, including organometallic complexes and chelates thereof;508          (I)  Phentermine;509          (J)  Pipradrol;510          (K)  Sibutramine; and511          (L)  SPA ((-)-1-dimethylamino-1,2-diphenylethane).512          (v)  Unless specifically excepted or unless listed in another schedule, any material,513     compound, mixture, or preparation which contains any quantity of dextropropoxyphene514     (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.515          (e)  Schedule V: Any compound, mixture, or preparation containing any of the516     following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous517     base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in518     sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal519     qualities other than those possessed by the narcotic drug alone:520          (i)  not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;521          (ii)  not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100522     grams;523          (iii)  not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100524     grams;525          (iv)  not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of526     atropine sulfate per dosage unit;527          (v)  not more than 100 milligrams of opium per 100 milliliters or per 100 grams;528          (vi)  not more than 0.5 milligram of difenoxin and not less than 25 micrograms of529     atropine sulfate per dosage unit;530          (vii)  unless specifically exempted or excluded or unless listed in another schedule, any531     material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant532     effect on the central nervous system, including its salts, isomers, and salts of isomers; and533          (viii)  all forms of Tramadol.534          Section 2.  Effective date.535          If approved by two-thirds of all the members elected to each house, this bill takes effect536     upon approval by the governor, or the day following the constitutional time limit of Utah537     Constitution, Article VII, Section 8, without the governor's signature, or in the case of a veto,538     the date of veto override.Legislative Review NoteOffice of Legislative Research and General Counsel

